logo
  • Home
  • Technologies
    • Live Cell Encapsulation
    • Research & Development
    • Cancer
    • Diabetes
    • Cannabinoids
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
    • International Diabetes Consortium
  • Investor Relations
    • Overview
    • News / Events
    • Shareholder Calls/Updates
    • Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News
    • Press Releases
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact
    • Social Media Community Guidelines

News

    • 10 DEC 2019
    • 0

    PharmaCyte Biotech to Hold Quarterly Shareholder Update

    LAGUNA HILLS, CA December 10, 2019 (BUSINESS NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that its quarterly shareholder update will be held on December 20, 2019, at 4:00 P.M. EST. The update will include

    Read more →
    • Posted in
    • News
    • 25 NOV 2019
    • 0

    PharmaCyte Biotech “Release Testing” Successful on All Completed Tests of Clinical Trial Product

    LAGUNA HILLS, Calif.–(BUSINESS WIRE)– PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today an update on the completed tests that are part of the U.S. Food and Drug Administration (FDA) required “release testing” related to the company’s first

    Read more →
    • Posted in
    • News
    • 18 NOV 2019
    • 0

    PharmaCyte Biotech Successfully Completes Final Manufacturing Run of Clinical Trial Product

    LAGUNA HILLS, CA 18, 2019 (BUSINESS NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that its partner, Austrianova Singapore (Austrianova), has successfully completed the second and final GMP manufacturing run to produce PharmaCyte’s clinical trial

    Read more →
    • Posted in
    • News
    • 04 NOV 2019
    • 0

    PharmaCyte Biotech Closer to Submitting IND by Successfully Completing Encapsulation of Second Manufacturing Run of Clinical Trial Product

    LAGUNA HILLS, CA November 4, 2019 (BUSINESS NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, is closer to submitting an Investigational New Drug application (IND) to the U.S. Food & Drug Administration (FDA). PharmaCyte announced today that

    Read more →
    • Posted in
    • News
    • 14 OCT 2019
    • 0

    PharmaCyte Biotech Successfully Completes Manufacturing of Clinical Trial Product

    LAGUNA HILLS, CA October 14, 2019 (BUSINESS NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that its partner, Austrianova Singapore (Austrianova), has completed the first of two staggered and back to back manufacturing runs for

    Read more →
    • Posted in
    • News
    • 01 OCT 2019
    • 0

    PharmaCyte Biotech Q&A Discussion with Cellular Biologist David A. Judd

    LAGUNA HILLS, CA October 1, 2019 (BUSINESS NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today the latest in its series of Q&A articles that are conducted with some of the key team members of PharmaCyte’s

    Read more →
    • Posted in
    • News
    • 25 SEP 2019
    • 0

    PharmaCyte Biotech Releases Shareholder Update Call Playback Information

    LAGUNA HILLS, Calif.–(BUSINESS WIRE)– PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that an audio recording of the company’s shareholder update call, which was held on September 20, 2019, by PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner,

    Read more →
    • Posted in
    • News
    • 16 SEP 2019
    • 0

    PharmaCyte Biotech Provides Information on Upcoming Shareholder Update Call

    LAGUNA HILLS, CA–(BUSINESS WIRE)—September 16, 2019 – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today provided the call information for PharmaCyte’s upcoming shareholder update call on September 20, 2019. The call is scheduled for Friday,

    Read more →
    • Posted in
    • News
    • 12 SEP 2019
    • 0

    PharmaCyte Biotech Releases Results of Shareholder Meeting and Provides Information on Upcoming Shareholder Update Call

    LAGUNA HILLS, CA–(BUSINESS WIRE)—September 12, 2019 – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced the results of the Special Shareholder Meeting and provides information on the shareholder update conference call scheduled for next week.

    Read more →
    • Posted in
    • News
    • 11 SEP 2019
    • 0

    PharmaCyte Biotech Holding Special Shareholder Meeting Today

    LAGUNA HILLS, CA–(BUSINESS WIRE)—September 11, 2019 – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced a reminder for shareholders that this morning a Special Shareholder Meeting will take place at the Courtyard Irvine Spectrum

    Read more →
    • Posted in
    • News
  • 1
  • 2
  • 3
  • ›
  • »

Contact Us

PharmaCyte Biotech Inc.
23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92653
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS

Latest News

  • PharmaCyte Biotech to Hold Quarterly Shareholder Update 2019-12-10T09:00:25-0500
  • PharmaCyte Biotech “Release Testing” Successful on All Completed Tests of Clinical Trial Product 2019-11-25T09:00:04-0500

Subscribe to Our Mailing List

* indicates required
Email Format